Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Optimization of Canalicular ABC Transporter Function in HuH-7 Cells by Modification of Culture Conditions

Hee Eun Kang, Melina M. Malinen, Chitra Saran, Paavo Honkakoski and Kim L.R. Brouwer
Drug Metabolism and Disposition October 2019, 47 (10) 1222-1230; DOI: https://doi.org/10.1124/dmd.119.087676
Hee Eun Kang
College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences, The Catholic University of Korea, Bucheon, South Korea (H.E.K.); Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy (H.E.K., M.M.M., C.S., P.H., K.L.R.B.) and Department of Pharmacology, UNC School of Medicine (C.S.), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; and School of Pharmacy, University of Eastern Finland, Kuopio, Finland (M.M.M., P.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hee Eun Kang
Melina M. Malinen
College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences, The Catholic University of Korea, Bucheon, South Korea (H.E.K.); Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy (H.E.K., M.M.M., C.S., P.H., K.L.R.B.) and Department of Pharmacology, UNC School of Medicine (C.S.), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; and School of Pharmacy, University of Eastern Finland, Kuopio, Finland (M.M.M., P.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chitra Saran
College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences, The Catholic University of Korea, Bucheon, South Korea (H.E.K.); Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy (H.E.K., M.M.M., C.S., P.H., K.L.R.B.) and Department of Pharmacology, UNC School of Medicine (C.S.), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; and School of Pharmacy, University of Eastern Finland, Kuopio, Finland (M.M.M., P.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paavo Honkakoski
College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences, The Catholic University of Korea, Bucheon, South Korea (H.E.K.); Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy (H.E.K., M.M.M., C.S., P.H., K.L.R.B.) and Department of Pharmacology, UNC School of Medicine (C.S.), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; and School of Pharmacy, University of Eastern Finland, Kuopio, Finland (M.M.M., P.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paavo Honkakoski
Kim L.R. Brouwer
College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences, The Catholic University of Korea, Bucheon, South Korea (H.E.K.); Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy (H.E.K., M.M.M., C.S., P.H., K.L.R.B.) and Department of Pharmacology, UNC School of Medicine (C.S.), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; and School of Pharmacy, University of Eastern Finland, Kuopio, Finland (M.M.M., P.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kim L.R. Brouwer
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Representative cellular morphology and bile canaliculi-like structures in 4-week HuH-7 cultures. (A) Phase-contrast microscopy image of 4-week confluent HuH-7 cells cultured without (standard) and with Matrigel overlay. (B) Localization of the fluorescent canalicular marker CDF, the metabolite of CDFDA, in 4-week standard and Matrigel-overlaid HuH-7 cultures.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Effect of Matrigel overlay and DEX on the length and number of bile canaliculi-like structures in confluent 4-week HuH-7 cultures. The (A) length (mean ± S.D.) and (B) number (mean ± S.D.) of phalloidin-stained F-actin-rich tubules (i.e., bile canaliculi) normalized by cell count on the basis of DAPI-labeled nuclei are shown. Each representative field view (212.55 × 212.55 μm) from three different wells per each condition was used for the measurement. *P < 0.05; ***P < 0.001 (one-way ANOVA with Games-Howell test).

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Expression and distribution of canalicular transporters MDR1, MRP2, and BSEP (green) in 4-week HuH-7 cultures without Matrigel overlay [(A) standard culture Area 1 and (B) Area 2]. Nuclei (blue) and F-actin (red) were labeled with DAPI and Alexa Fluor 594-phalloidin, respectively.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Expression and distribution of canalicular transporters (A) MDR1, (B) MRP2, and (C) BSEP (green) in 4-week HuH-7 cultures with Matrigel overlay. HuH-7 cells were overlaid with Matrigel on culture day 22 and supplemented with 0, 0.1, or 1 μM DEX from culture day 8 to 28. Nuclei (blue) and F-actin (red) were labeled with DAPI and Alexa Fluor 594-phalloidin, respectively.

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Effect of DEX on the expression of MDR1, MRP2, and BSEP in 4-week HuH-7 cultures overlaid with Matrigel on culture day 22. (A) Representative immunoblots of MDR1, MRP2, BSEP, and Na+/K+ ATPase in 4-week Matrigel-overlaid HuH-7 cultures and cryopreserved human hepatocytes (positive control). (B) Relative expression levels (mean ± S.D.) of MDR1, MRP2, and BSEP in 4-week Matrigel-overlaid HuH-7 cultures supplemented with 0, 0.1, and 1 μM DEX from culture day 8 to 28 (n = 2–4 each). ***P < 0.001 (one-way ANOVA with Tukey’s test).

  • Fig. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Accumulation of CDF in 4-week HuH-7 cultures. HuH-7 cells cultured with or without Matrigel overlay were preincubated with standard or Ca2+-free HBSS for 25 minutes followed by incubation for 20 minutes with CDFDA. Accumulation of CDF, the fluorescent metabolite of CDFDA, within canaliculi-like structures is indicated by arrows.

  • Fig. 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 7.

    Effect of Matrigel overlay and DEX on digoxin and pravastatin accumulation and canalicular excretion in 4-week HuH-7 cultures. Accumulation of (A) digoxin and (B) pravastatin was measured in cells + bile (preincubation with standard HBSS) and in cells (preincubation with Ca2+-free HBSS). Results represent mean ± S.D. of two independent studies performed in triplicate. BEI (mean, %) was calculated as described in Materials and Methods.

  • Fig. 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 8.

    Effect of Matrigel overlay and DEX on TCA accumulation and canalicular excretion in 4-week HuH-7 cultures. Accumulation of [3H]-TCA in the cells+bile (preincubation with standard HBSS) and in cells (preincubation with Ca2+-free HBSS). Results represent mean ± S.D. of three independent studies performed in triplicate. BEI (mean ± S.D., %) was calculated as described in Materials and Methods.

Tables

  • Figures
  • Additional Files
    • View popup
    TABLE 1

    Summary of biliary excretion index (BEI), apparent in vitro uptake clearance (CLuptake,app) and biliary clearance (CLbiliary,app) values of digoxin, pravastatin, and TCA in various hepatic cell models

    Substrates/ParametersIn Vitro Hepatic Models
    HuH-7Sandwich-Cultured Human HepatocytesaHepaRGa
    Digoxin
     BEI (%)27–297–63b–d
     CLuptake,app (μl/min per milligram protein)1.0–1.30.69–2.8b,d
     CLbiliary,app (μl/min per milligram protein)0.3–0.360.18–2.4b–d
    Pravastatin
     BEI (%)2218–3c,e
     CLuptake,app (μl/min per milligram protein)0.41e
     CLbiliary,app (μl/min per milligram protein)0.0860.25–0.55c,e
    TCA
     BEI (%)26–5030–75b,d–f27–39g–i
     CLuptake,app (μl/min per milligram protein)1.2–2.12.7–20b,d–f2.7–13.8g,h
     CLbiliary,app (μl/min per milligram protein)0.5–0.70.8–25b,d–f1–4g,h
    • ↵a The values were adopted or calculated from the following references:

    • ↵b Bi et al. (2006).

    • ↵c Kimoto et al. (2017).

    • ↵d Swift et al. (2009).

    • ↵e Abe et al. (2009).

    • ↵f Ni et al. (2016).

    • ↵g Le Vee et al. (2013).

    • ↵h Susukida et al. (2016).

    • ↵i Bachour-El Azzi et al. (2015).

Additional Files

  • Figures
  • Tables
  • Data Supplement

    • Supplemental Figures -

      Supplementary Figure 1 -  Bile canaliculi-like structures of confluent 4-week HuH-7 cultures overlaid with Matrigel extracellular matrix.

      Supplementary Figure 2 - Effect of dexamethasone (DEX) on the expression of BSEP in standard HuH-7 cultures.

      Supplementary Figure 3 - Effect of Matrigel lots and phenol red on TCA canalicular excretion in 4-week HuH-7 cultures supplemented with 1 μM dexamethasone (DEX).


PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 47 (10)
Drug Metabolism and Disposition
Vol. 47, Issue 10
1 Oct 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Optimization of Canalicular ABC Transporter Function in HuH-7 Cells by Modification of Culture Conditions
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Canalicular ABC Transporters in HuH-7 Cells

Hee Eun Kang, Melina M. Malinen, Chitra Saran, Paavo Honkakoski and Kim L.R. Brouwer
Drug Metabolism and Disposition October 1, 2019, 47 (10) 1222-1230; DOI: https://doi.org/10.1124/dmd.119.087676

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Canalicular ABC Transporters in HuH-7 Cells

Hee Eun Kang, Melina M. Malinen, Chitra Saran, Paavo Honkakoski and Kim L.R. Brouwer
Drug Metabolism and Disposition October 1, 2019, 47 (10) 1222-1230; DOI: https://doi.org/10.1124/dmd.119.087676
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • A PBPK model for CBD in adults and children
  • Olanzapine Glucuronidation in Humanized Mice
  • rs2242480 Regulates the Expression of CYP3A4 and CYP3A5
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics